Table 2.

Composition of SLN and NLC formulations prepared with Precirol® ATO5, Compritol® 888 ATO or 1:1 w/w ratio of the two as solid lipid matrix, Miglyol® 812 as the liquid lipid at various concentrations (10, 20 and 30% w/w of the lipid phase), and Tween® 80 or Pluronic® F-68 as surfactants, either blank or loaded with curcumin.

Formulation	Compound concentration (% w/w)
	Compritol® 888 ATO	Precirol® ATO 5	Miglyol® 812	Tween® 80	Pluronic® F-68	Curcumin	Water
B-SLN1	2.5	-	-	1.2	-	-	96.3
B-NLC1	2.25	-	0.25	1.2	-	-	96.3
B-NLC2	2.0	-	0.5	1.2	-	-	96.3
B-NLC3	1.75	-	0.75	1.2	-	-	96.3
SLN1	2.4875	-	-	1.2	-	0.0125	96.3
NLC1	2.2388	-	0.2487	1.2	-	0.0125	96.3
NLC2	1.99	-	0.4975	1.2	-	0.0125	96.3
NLC3	1.7413	-	0.7462	1.2	-	0.0125	96.3
SLN2	-	2.4875	-	1.2	-	0.0125	96.3
NLC4	-	1.7413	0.7462	1.2	-	0.0125	96.3
SLN3	1.2438	1.2437	-	1.2	-	0.0125	96.3
NLC5	0.8707	0.8707	0.7461	1.2	-	0.0125	96.3
SLN4	2.4875	-	-	0.5	-	0.0125	97
SLN5	2.4875	-	-	-	1.2	0.0125	96.3